Institute for Advanced Study, School of Natural Sciences, Princeton, NJ 08540, USA.
Genetics Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cancer Cell. 2019 Jan 14;35(1):10-15. doi: 10.1016/j.ccell.2018.11.009.
We propose that initiating truncal mutations plays a special role in tumor formation by both enhancing the survival of the initiating cancer cell and by selecting for secondary mutations that contribute to tumor progression, and that these mutations often act in a tissue-preferred fashion. Here, we explain why inherited mutations often have different tissue specificities compared with spontaneous mutations in the same gene. Initiating truncal mutations make excellent neo-antigens for immunotherapy, and understanding why one mutation selects for a second mutation in a particular tissue type could one day aid in the design of gene-targeted combination therapies.
我们提出,引发种系突变通过增强起始癌细胞的存活能力和选择有助于肿瘤进展的二次突变,在肿瘤形成中发挥特殊作用,并且这些突变通常以组织偏好的方式发挥作用。在这里,我们解释为什么与同一基因中的自发突变相比,遗传突变通常具有不同的组织特异性。起始种系突变是免疫治疗的极好的新抗原,了解为什么一种突变会在特定组织类型中选择第二种突变,有朝一日可能有助于设计基因靶向联合疗法。